Sennheiser announced that new components of the EW-DX microphone system are shipping and available to customers. With initial components released in 2022, EW-DX simplifies professional workflows by ...

The QIAstat-Dx panel will provide actionable insights in about one hour, analyzing more than 20 pathogens that cause meningitis / encephalitis syndromes, including bacteria, viruses and yeast and ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of all QIAstat-Dx® Gastrointestinal (GI) Panels on the ...

QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced ...

Berkeley Prep’s brand-new chapel relies on Sennheiser EW-DX for services. Berkeley Preparatory School, a Pre-K to Grade 12 day school in Tampa, has a jam-packed schedule of activities for its 1,400+ ...

Screening cancer patients for microsatellite instability (MSI) can provide pathologists, oncologists, and patients with information that characterizes tumors to help guide care and make more informed ...

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX ™ Opus 96 Dx System and the CFX ™ Opus 384 Dx System, ...

The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing. Bio-Rad Laboratories, Inc.

QIAGEN N.V. QGEN recently achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel for the ...

Venlo, the Netherlands, March 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the release of the QIAstat-Dx Analyzer 2.0, including the Software ...